Yunu Enhances Pediatric Oncology Research by Appointing Dr. Scott Bradfield as Strategic Advisor

Yunu, a leading provider of clinical trial imaging workflow and data management solutions, has announced the appointment of Dr. Scott Bradfield, a distinguished pediatric oncologist, as a strategic advisor. This collaboration aims to enhance the precision of pediatric oncology trials with advanced imaging technology. Dr. Bradfield brings extensive experience from his roles at Nemours Children's Health - Jacksonville, including overseeing over 40 clinical trials as the Institutional Principal Investigator for the Children's Oncology Group (COG).

COG, supported by the National Cancer Institute, is the largest organization globally dedicated to research on cancer in children and adolescents. Yunu's platform, already supporting 20% of COG's imaging protocols, strengthens the link between the imaging community and researchers focusing on rare disease cancers. Dr. Bradfield's addition to the team aims to close workflow and data management gaps in pediatric oncology research, leveraging Yunu's capabilities to improve study protocols and patient outcomes.

With over 25% of NCI-designated cancer centers using Yunu's cloud-based platform for managing clinical trials, the platform has significantly improved protocol compliance, study starts, and patient enrollment. Dr. Bradfield emphasizes the importance of utilizing imaging technology for accelerating the development of effective therapies. His career, spanning two decades, demonstrates a committed effort toward advancing pediatric oncology research and care.